Table 3.
Pearson correlation analysis of parameters associated with FT3.
| Variable | No NAFLD (n = 506) | NAFLD (n = 353) | ||
|---|---|---|---|---|
| r | P | r | P | |
| Age | -0.148 | <0.01 | -0.342 | <0.01 |
| T2DM duration | -0.062 | ns | -0.187 | ns |
| BMI | 0.057 | ns | 0.020 | ns |
| SBP (mmHg) | 0.025 | ns | -0.560 | ns |
| DBP (mmHg) | 0.900 | ns | 0.690 | ns |
| FINS (pmol/L) | -0.032 | ns | -0.014 | ns |
| FCP (nmol/L) | -0.049 | ns | 0.037 | ns |
| 2h-CP (nmol/L) | 0.020 | ns | 0.056 | ns |
| ABG (mmol/L) | -0.165 | <0.01 | -0.204 | <0.01 |
| FBG (mmol/L) | -0.099 | <0.05 | -0.069 | ns |
| 2hBG (mmol/L) | -0.019 | ns | -0.083 | ns |
| HbA1c | -0.128 | <0.05 | -0.173 | <0.01 |
| HOMA-IR | -0.026 | ns | -0.049 | ns |
| HOMA-β | -0.011 | ns | 0.036 | ns |
| TSH (mU/L) | -0.139 | <0.05 | -0.125 | <0.05 |
| FT4 (pmol/L) | -0.019 | ns | -0.058 | ns |
| ALT (U/L) | 0.023 | ns | 0.174 | <0.01 |
| AST (U/L) | -0.050 | ns | 0.013 | ns |
| GGT (U/L) | -0.056 | ns | 0.089 | ns |
| UN (mmol/L) | -0.105 | <0.05 | -0.117 | <0.05 |
| CR (μmol/L) | -0.040 | ns | -0.158 | <0.01 |
| UA (μmol/L) | -0.058 | ns | 0.012 | ns |
| TG (mmol/L) | -0.084 | ns | 0.007 | ns |
| TC (mmol/L) | 0.009 | ns | 0.062 | ns |
| HDL-C (mmol/L) | -0.073 | ns | -0.124 | <0.05 |
| LDL-C (mmol/L) | 0.041 | ns | 0.202 | <0.01 |
| GFR (mL min−1 1.73 m−2) | -0.400 | ns | 0.173 | <0.01 |
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FINS: fasting insulin; FCP: fasting C peptide; ABG: admission blood glucose; FBG: fasting blood glucose; HbA1c: glycated hemoglobin; TSH: thyroid-stimulating hormone; FT3: free triiodothyronine; FT4: free four iodothyronine; ALT: alanine transferase; AST: aspartate aminotransferase; GGT: glutamyl transpeptidase; UN: urea nitrogen; CR: creatinine; UA: uric acid; TG: triglycerides; TC: total cholesterol; HDL: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; GFR: glomerular filtration rate; CRP: C-reactive protein; 2hBG: 2 h blood glucose; 2hINS: 2 h insulin; 2h-CP, 2 h C peptide; HOMA-IR: homeostasis model assessment-insulin resistance; HOMA-β: homeostasis model assessment-β. P < 0.05 was considered statistically significant.